Verseau Therapeutics
PrivateLast Round
Series B
Oct 21, 2019
Total Funding Raised
$104.3M
Company Overview
Verseau Therapeutics is a biotechnology company that develops macrophage checkpoint modulators to treat cancer and immune-related inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Verseau Therapeutics Comparables
Compare Verseau Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DEM BioPharma | 85% | |
| Immune-Onc Therapeutics | 82% | |
| OncoResponse | 80% | |
Verseau Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 21, 2019 | ||||
| Series B | Feb 12, 2019 |
Verseau Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series B |
| Highlight Capital | Series B |
| Yonghua Capital | Series B |
| The Mark Foundation for Cancer Research | Series B, Series A |
| Alexandria Venture Investments | Series B |
| 20/20 HealthCare Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 12, 2019
$50M raised from Alexandria Venture Investments and Yonghua Capital.
Verseau Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Verseau Therapeutics's valuation, stock price, and market status.